发明名称 |
Novel pharmaceutical formulations |
摘要 |
<p>There is provided inter alia a dry powder pharmaceutical formulation for inhalation comprising: (i) 6-(2-((4-amino-3-(3-hydroxyphenyl)-1 H-pyrazolo[3,4-d]pyrimidin-1-yl) methyl)-3- (2-chlorobenzyl)-4-oxo-3,4-dihydroquinazolin-5-yl)-N, N-bis(2-methoxyethyl)hex-5- ynamide or a pharmaceutically acceptable salt thereof, including all stereoisomers, tautomers and isotopic derivatives thereof and solvates thereof in particulate form as active ingredient; (ii) particulate lactose as carrier; and (iii) a particulate stabilizing agent selected from metal salts of stearic acid such as magnesium stearate and metal salts of stearyl fumarate.</p> |
申请公布号 |
AU2013234080(A1) |
申请公布日期 |
2014.08.21 |
申请号 |
AU20130234080 |
申请日期 |
2013.03.13 |
申请人 |
RESPIVERT LIMITED |
发明人 |
BROECKX, RUDY LAURENT MARIA;FILLIERS, WALTER FERDINAND MARIA;NIESTE, PATRICK HUBERT J.;COPMANS, ALEX HERMAN;VANHOUTTE, FILIP MARCEL C.;LEYS, CARINA |
分类号 |
C07D487/04;A61K9/00;A61K47/12;A61K47/26 |
主分类号 |
C07D487/04 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|